Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response
Gabriele Floris, Sarah J. Jefferson, Jocelyne Rondeau, Abigail L. Yu, Frank S. Menniti, Alex C. Kwan, Joao P. De Aquino, John H. Krystal, Christopher Pittenger, Alfred P. Kaye Neuropsychopharmacology
· Springer Nature
· 2026-10-12
· DOI: 10.1038/s41386-026-02569-x
Аннотация
Neuropsychopharmacology, Published online: 12 October 2026; doi:10.1038/s41386-026-02569-x Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response
Gabriele Floris, Sarah J. Jefferson, Jocelyne Rondeau, Abigail L. Yu, Frank S. Menniti, Alex C. Kwan et al. Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response. // Neuropsychopharmacology. – 2026. – DOI: 10.1038/s41386-026-02569-x. – URL: https://www.nature.com/articles/s41386-026-02569-x
Gabriele Floris, Sarah J. Jefferson, Jocelyne Rondeau, Abigail L. Yu, Frank S. Menniti, Alex C. Kwan, Joao P. De Aquino, John H. Krystal, Christopher Pittenger, & Alfred P. Kaye (2026). Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response. Neuropsychopharmacology. https://doi.org/10.1038/s41386-026-02569-x
Gabriele Floris, et al. “Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response.” Neuropsychopharmacology, 2026. doi:10.1038/s41386-026-02569-x.
@article{Floris2026,
title = {Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response},
author = {Floris, Gabriele and Jefferson, Sarah J. and Rondeau, Jocelyne and Yu, Abigail L. and Menniti, Frank S. and Kwan, Alex C. and Aquino, Joao P. De and Krystal, John H. and Pittenger, Christopher and Kaye, Alfred P.},
journal = {Neuropsychopharmacology},
year = {2026},
doi = {10.1038/s41386-026-02569-x},
url = {https://www.nature.com/articles/s41386-026-02569-x}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...